Chemotherapy for Kidney Cancer: When and How It’s Used
Understand when chemotherapy is used for kidney cancer, how it works, side effects, and what patients can expect from treatment.
Chemotherapy, commonly known as chemo, uses potent drugs to destroy rapidly growing cancer cells. While chemo is a mainstay for various cancers, its application in kidney cancer—particularly the most common type, renal cell carcinoma (RCC)—is limited due to low effectiveness. Still, for certain rare subtypes, chemotherapy can play an essential role. This comprehensive guide explains when chemotherapy is considered for kidney cancer, how it works, what drugs are used, potential side effects, and what patients should expect during treatment.
Understanding Kidney Cancer and Chemotherapy
Kidney cancer typically originates in the kidneys as abnormal cells begin multiplying out of control. The vast majority (around 90%) of adult kidney cancers are a variety called renal cell carcinoma (RCC). Other forms, such as collecting duct carcinoma, renal medullary carcinoma, and pediatric Wilms tumor, exhibit different characteristics and responses to treatment.
Treatment for kidney cancer often involves surgery, immunotherapy, and targeted therapy. Chemotherapy, which uses drugs to disrupt the division and growth of cancer cells, is less commonly effective for kidney cancer compared to other cancers. However, in particular cases, such as rarer forms of kidney cancer or after other treatments fail, chemo may offer benefits.
How Does Chemotherapy Work?
Cancer cells typically grow and divide more quickly than normal cells. Chemotherapy exploits this by deploying drugs that specifically target rapidly dividing cells. This allows chemotherapy to kill cancer cells or slow their growth. Unfortunately, because RCC cells don’t always respond well to these drugs, the use of chemotherapy is selective in kidney cancer cases.
- Chemo drugs travel throughout the body, making them effective at targeting cancer that has spread beyond the kidneys.
- However, they can also affect normal fast-growing cells, leading to side effects.
When Is Chemotherapy Used for Kidney Cancer?
Chemotherapy is not commonly used for standard cases of RCC due to its low response rate. Instead, other treatments such as surgery, targeted therapy (drugs that attack specific cancer cell features), and immunotherapy (which stimulates the immune system to fight cancer) are preferred. However, in specific situations, chemotherapy is considered:
- Rare kidney cancer subtypes: Chemo is more likely to be used for collecting duct carcinoma, renal medullary carcinoma, and urothelial carcinoma, which may show greater responsiveness to these drugs.
- Pediatric cases: Children with Wilms tumor almost always receive some form of chemotherapy, often as part of a multi-modality approach.
- When other therapies fail: If targeted therapies or immunotherapies are not effective, chemotherapy may be considered as a later-line treatment or as part of a clinical trial.
What others are reading
The Effectiveness of Chemotherapy in Kidney Cancer
While chemo is a crucial tool for many cancers, the majority of kidney cancers are relatively chemo-resistant. RCC, the most frequent type, doesn’t respond strongly to most chemo drugs. This is in contrast to subtypes like collecting duct and medullary carcinoma, for which chemo can potentially be more effective.
Chemotherapy may also be more appropriate if the cancer has already spread (metastasized) and other treatments are not suitable or have failed. Doctors evaluate cases individually to determine if chemotherapy could provide benefit, often weighing the potential for response against side effects and prior treatment history.
| Kidney Cancer Type | Chemo Responsiveness | First-line Treatment |
|---|---|---|
| Clear cell RCC | Poor | Immunotherapy, Targeted Therapy |
| Collecting duct carcinoma | Moderate | Often Chemotherapy |
| Renal medullary carcinoma | Moderate | Chemotherapy |
| Wilms tumor (children) | High | Chemotherapy + Surgery |
| Urothelial carcinoma of renal pelvis | Moderate/High | Chemotherapy |
Chemotherapy Drugs Used in Kidney Cancer
The choice of chemotherapy drugs depends largely on the type of kidney cancer and previous treatment history. Notable medications include:
- Gemcitabine
- Cisplatin or Carboplatin (types of platinum drugs)
- Paclitaxel
- 5-Fluorouracil (5-FU)
- Capecitabine
- Doxorubicin
- Dactinomycin (specifically for Wilms tumor)
- Vincristine (Wilms tumor and others)
- Cyclophosphamide
- Etoposide
Platinum agents (cisplatin or carboplatin) combined with gemcitabine or paclitaxel are frequent combinations for non-clear cell types. In pediatric patients, multi-drug regimens are used for Wilms tumor. Sometimes, chemotherapy drugs are combined with newer immunotherapy or targeted therapy drugs.
How Is Chemotherapy Administered?
Chemotherapy for kidney cancer can be delivered in multiple ways depending on the specific drugs, treatment plan, and patient needs.
- Intravenous (IV) infusion: The most common method, where drugs are administered through a vein over a period of time, often using a temporary port or catheter for easier vein access.
- Oral medications: Some chemo drugs can be taken as pills or capsules at home.
- Injection: Less commonly, drugs are injected directly into a vein, muscle, or under the skin.
Treatments are typically given in cycles, each comprising a period of active treatment followed by a rest period to allow healthy cells to recover. Each cycle usually lasts several weeks, with the exact schedule tailored to the individual’s needs and response to therapy.
Inpatient vs. Outpatient Chemotherapy
- Inpatient: Requires an overnight hospital stay for more intensive treatment or observation.
- Outpatient: Most chemo sessions for kidney cancer are outpatient, allowing patients to return home the same day.
What Is the Chemotherapy Procedure Like?
Before starting chemotherapy, patients undergo comprehensive testing to establish overall health and baseline organ function. This is important, as some chemo drugs can themselves affect kidney function, which may already be compromised in kidney cancer patients. The procedure typically includes:
- Planning and scheduling: Discussions with your oncologist about the schedule, expected outcomes, and potential need for additional supportive care.
- IV access placement: For frequent infusions, a port or catheter may be implanted for easier repeated access to large veins.
- Active treatment: Drugs are administered following the prescribed schedule, varying from weekly to every few weeks depending on the drugs and cycle.
- Monitoring: Patients are monitored for both immediate reactions and longer-term side effects.
- Rest period: After a block of treatment, rest allows recovery of blood counts and reduction of toxicity before the next cycle begins.
Side Effects of Chemotherapy in Kidney Cancer
Chemotherapy drugs not only impact cancer cells but can also affect normal, fast-growing healthy cells. This is why chemo has a range of side effects, which vary based on drug type, dosage, and individual response.
| Common Side Effect | Description/Impact |
|---|---|
| Fatigue | Low red blood cells can cause extreme tiredness and weakness. |
| Increased Infections | Low white blood cells result in higher risk of infections. |
| Bruising/Bleeding | Reduced blood platelets may make bleeding and bruising more likely. |
| Mouth Sores | Damage to mouth lining leads to painful sores. |
| Nausea & Vomiting | Many chemo drugs cause digestive upset. |
| Loss of Appetite | Chemo can alter taste and appetite. |
| Hair Loss | Impact on hair follicle cells may result in hair thinning or full loss. |
| Peripheral Neuropathy | Nerve damage from certain chemo drugs may lead to pain, tingling, or numbness in hands and feet. |
| Kidney and bladder problems | Some drugs are potentially toxic to the kidneys or bladder, requiring close monitoring. |
- Many side effects resolve after treatment ends, but some (such as nerve damage) can be long-lasting.
- Medications are available to manage or mitigate some side effects—discuss all symptoms with your care team for supportive therapy options.
Precautions and Considerations
- People with reduced kidney function or other chronic conditions may require adjusted dosages or alternative treatments to minimize risk.
- Regular blood tests and organ function tests are required to ensure safety during chemotherapy.
- Effective communication with your care team about new symptoms, side effects, or concerns is essential for safe and optimized care.
Outlook and Next Steps After Chemotherapy
The outlook for kidney cancer patients undergoing chemotherapy depends on several factors, including cancer type, stage at diagnosis, overall health, and response to previous treatments. As chemo is often not the first-line therapy for RCC, it’s generally used when other options are exhausted or for harder-to-treat subtypes.
- Palliative benefit is possible, even if complete response is rare in RCC.
- Close monitoring ensures that any side effects are managed early, and treatment can be stopped or changed if not effective.
- Some patients may be eligible for clinical trials investigating new combinations or drugs, offering potential access to newly emerging therapies.
Frequently Asked Questions (FAQs)
Q: Is chemotherapy usually the first treatment for kidney cancer?
A: For the most common type—renal cell carcinoma—it is not the first line. Treatments like surgery, targeted therapy, or immunotherapy are preferred. Chemo is primarily considered for rarer subtypes or when other treatments have not worked.
Q: What kinds of kidney cancer types are more sensitive to chemotherapy?
A: Collecting duct carcinoma, renal medullary carcinoma, and Wilms tumor (in children) are more responsive than the clear-cell version of RCC.
Q: What are the most common side effects of chemotherapy for kidney cancer?
A: Fatigue, infection risk, nausea, vomiting, mouth sores, hair loss, and nerve problems. Most are temporary but should be reported to your care team for management.
Q: Can chemotherapy cure kidney cancer?
A: It is unlikely to cure the most common form (RCC) but may be part of a curative regimen for children with Wilms tumor and some rarer adult tumor types when used alongside other therapy.
Q: How is the effectiveness of chemotherapy monitored?
A: Through physical exams, imaging (like CT scans), and blood tests at regular intervals. Your response helps inform adjustments to the treatment plan.
Conclusion
Chemotherapy is a vital but selectively used tool in the management of kidney cancer. While not effective for all types, it remains important in certain subtypes and in cases where other therapies have failed. If you or a loved one is facing kidney cancer and chemotherapy is being considered, an open dialogue with your healthcare team will help clarify expectations, manage side effects, and ensure the best possible outcome based on individual circumstances.
References
- https://www.cancer.org/cancer/types/kidney-cancer/treating/chemotherapy.html
- https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=34&contentid=17774-1
- https://www.healthline.com/health/kidney-cancer/chemo-for-kidney-cancer
- https://my.clevelandclinic.org/health/diseases/9409-kidney-cancer-overview
- https://www.dana-farber.org/cancer-care/types/kidney-cancer/treatment
- https://www.cancer.org/cancer/types/kidney-cancer/treating/targeted-therapy.html
- https://www.cancerresearchuk.org/about-cancer/kidney-cancer/treatment/decisions
- https://www.mayoclinic.org/diseases-conditions/kidney-cancer/diagnosis-treatment/drc-20352669
- https://www.cancer.gov/types/kidney/hp/kidney-treatment-pdq
Similar Articles
Read full bio of Sneha Tete
